The Efficacy & Safety of a Single 70% Glycolic Acid Peel With Vitamin C

Status Not yet recruiting

Clinical Trial Summary

Our study involves the evaluation of a high potency peel in its efficacy for skin rejuvenation in the treatment of photoaging. This chemical peel regime is a high potency peel 70% glycolic acid combined with vitamin C that is purported to provide a good balance between yielding results and patient safety.

AIM We aim to qualitatively evaluate its efficacy and safety profile.

Our hypothesis is that a single peel of 70% glycolic acid combined with vitamin C will result in improvement of the features of photoaging with few side effects.

Clinical Trial Description

1. Assessment of photoaging to compare using photography A and E - for static analysis.

For each element from ii to xi, a rating of nil (0), mild (l), moderate (2), and severe (3) for each category was made by the same evaluating physician.

i. Physician VAS scale - assessment of wrinkles prepeel, post peel (Score 1 -10).

ii.Fine peri-orbital wrinkles (less than 1 mm in width or depth) (FPW); iii.Course peri-orbital wrinkles (greater than 1 mm in width and depth) (CPW); iv.Upper lip wrinkles (ULW); v.Lower lip wrinkles (LLW); vi.Melasma defined as blotchy, brown, epidermal macules with indistinct margins; vii.Solar lentigines defined as dark brown macules with distinct margins measuring from 3 to 10 mm; viii.Solar keratoses defined as diffuse erythema with keratotic adherent scaling; ix.Guttate hypomelanosis defined as localized macules of absent melanin measuring from 3 to 10 mm in diameter; x.Poikiloderma defined as a symmetrical reddish-brown pigmentation of the neck, typically sparing the sub-mental area;

The totaling of the scores of the above parameters will form a prepeel score. This will be compared against the patient's score post peel - we expect to find an improvement.

2. Safety profile assessment

- redness, swelling, oozing, hyperpigmentation, scarring

- each of the 5 parameters will be scored from 0 -3, none, mild, moderate, severe

- this will serve as a safety assessment. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Photoaging

Clinical Trial Details

NCT number	NCT02126644
Study type	Interventional
Source	National University Hospital, Singapore
Contact	Sam SY Yang, Dr
Phone	85333992
Email	samsyyang@gmail.com
Status	Not yet recruiting
Phase	Phase 2
Start date	May 2014
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05271136` - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum	N/A
Completed	`NCT05514782` - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum	N/A
Completed	`NCT04911374` - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream	N/A
Completed	`NCT04586816` - Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging	N/A
Not yet recruiting	`NCT05004909` - Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream	N/A
Completed	`NCT05039723` - Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational	Phase 4
Completed	`NCT06366503` - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation	N/A
Completed	`NCT05027282` - Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment	N/A
Not yet recruiting	`NCT06096649` - The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin	N/A
Not yet recruiting	`NCT06029725` - RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin	N/A
Completed	`NCT03661697` - Combination Versus Laser Treatment Only	N/A
Completed	`NCT03948945` - Efficacy and Safety of Profile HaloTM Mixed Fractional Laser on Treating of Facial and Neck Photoaging.	N/A
Completed	`NCT06148558` - A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+	N/A
Enrolling by invitation	`NCT06188338` - A 56-day Clinical Study on Facial Skin Rejuvenation	N/A
Not yet recruiting	`NCT04869852` - Effects of Mango Intake on Skin Health and Gut Microbiome Changes in Postmenopausal Women	N/A
Active, not recruiting	`NCT01372566` - Effect of Platelet Rich Plasma on Photoaged Skin	Phase 1/Phase 2
Unknown status	`NCT00842907` - Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage	Phase 2
Completed	`NCT03112863` - Comparison of the Cosmetic Effects of Bakuchiol and Retinol	Early Phase 1
Recruiting	`NCT05386368` - RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients	Phase 4
Recruiting	`NCT05471947` - TCA 15% Chemical Peel for Improvement in Hand Lentigines	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms